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*Salmonella enterica* subsp. *enterica* serovar Infantis is a nontyphoid emerging serovar showing increased morbidity in humans worldwide. Recent studies have shown that some emergent *S*. Infantis isolates carry a self-transmissible megaplasmid that confers stress tolerance and promotes pathogenicity, which can be horizontally transferred to the gut microbiota by conjugation ([@B1], [@B2]). *S*. Infantis plasmids are thus responsible for the dissemination of genes encoding extended spectrum beta-lactamases and quinolone resistance determinants ([@B3]). Surveillance studies also reveal an increased presence of *S*. Infantis in poultry meat ([@B3]), as well as prevalence in human persistent infections caused by nontyphoidal *Salmonella* serovars ([@B4]).

*S*. Infantis strain SPE101 was isolated from the feces of a 5-month-old breast-fed female in a pediatric unit of a public hospital in Lima, Peru, 4 months after initial hospitalization. The patient showed signs of dehydration and malnutrition when hospitalized. The *Salmonella* infection persisted for 6 months despite several regimens of beta-lactams, quinolone, and trimethoprim-sulfamethoxazole antibiotic treatments. Prior to genome sequencing, the SPE101 isolate was typified as *S*. Infantis by multiplex PCR (O and H antigens) and determined to belong to sequence type 32 (ST32) by multilocus sequence typing. The plasmid profile of this isolate revealed the presence of an \~250-kb megaplasmid, similar in size to the megaplasmid pESI reported in emergent *S*. Infantis isolates ([@B1]). PCR assays demonstrated the presence of the pESI backbone gene *traC* ([@B5]). Antimicrobial susceptibility tests performed according to the Clinical and Laboratory Standards Institute ([@B6]) showed resistance to beta-lactams and quinolones.

Genomic DNA from an overnight culture of SPE101 was obtained using the phenol-chloroform extraction method ([@B7]). Paired-end (2 × 150) sequencing was performed using the Illumina MiSeq platform (Illumina, Inc, San Diego, CA, USA). A total of 6,145,442 reads were generated. *De novo* assembly was conducted using an algorithm based on the de Brujin graphs ([@B8]), resulting in 63 contigs ≥ 500 bp with a 168-fold average coverage. The annotation was performed with the RAST algorithm ([@B9]). The draft genome of SPE101 contains 4,985,409 bp, with a 52.1% G+C content, and has 4,805 protein coding sequences, 11 rRNAs, 75 tRNAs, and 201 pseudogenes.

The 4,805 predicted SPE101 proteins were searched using tBLASTn in the 75 genomes of *S*. Infantis isolates deposited in GenBank by April 2017. Seven proteins were not encoded by any other available genome of *S*. Infantis. Among them were two putative transcriptional regulators, a proline-rich protein, and proteins encoded by a lambdoid phage. Interestingly, 266 of the 286 genes annotated in the pESI megaplasmid of the emergent *S*. Infantis strain 119944 reported in Israel ([@B1]) were found in SPE101.

Further analyses with derivative strains of SPE101 lacking the genes absent in other *S*. Infantis isolates may provide the foundation toward unraveling novel attributes of this emergent serovar in human salmonellosis.
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This draft genome project has been deposited at DDBJ/ENA/GenBank under the accession number [NBAV00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBAV00000000) (BioProject PRJNA380335; BioSample SAMN06640695). The version described in this paper is the first version, NBAV01000000.
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